Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments contribution in clinic: state of the art. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.1034684. PMID:36389064. IF:4.800(Q2/3D).

Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Camposs, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Terrancle, A, Prefasi, D, Lleo, A, Maurino, J. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2022; 90(2)DOI:10.3233/JAD-220696. PMID:36155523. IF:4.000(Q2/4D).

Gómez de San José N., Goossens J., Al Shweiki M.R., Halbgebauer S., Oeckl P., Steinacker P., Danzer K.M., Graf H., Schönfeldt-Lecuona C., Belbin O., Lleó A., Vanmechelen E., Otto M.. Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders. JOURNAL OF PSYCHIATRIC RESEARCH. 2022; 156DOI:10.1016/j.jpsychires.2022.10.010. PMID:36323141. IF:4.800(Q2/4D).

del Campo M., Peeters C.F.W., Johnson E.C.B., Vermunt L., Hok-A-Hin Y.S., van Nee M., Chen-Plotkin A., Irwin D.J., Hu W.T., Lah J.J., Seyfried N.T., Dammer E.B., Herradon G., Meeter L.H., van Swieten J., Alcolea D., Lleó A., Levey A.I., Lemstra A.W., Pijnenburg Y.A.L., Visser P.J., Tijms B.M., van der Flier W.M., Teunissen C.E.. CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nature Aging. 2022; 2(11)DOI:10.1038/s43587-022-00300-1. PMID:37118088. IF:(Q/D).